Role of Creation of Plain Language Summaries to Disseminate COVID-19 Research Findings to Patients With Rheumatic Diseases
J Rheumatol
.
2024 May 1;51(5):538-539.
doi: 10.3899/jrheum.2023-0998.
Authors
Mithu Maheswaranathan
1
,
Akpabio Akpabio
2
,
Laura-Ann Tomasella
3
,
Ariella Coler-Reilly
4
,
Dawn P Richards
5
,
Richard A Howard
6
,
Nadine Ladone
7
,
Emily Sirotich
;
COVID-19 Global Rheumatology Alliance, C19-GRA Patient Directed Summaries Team.
Affiliations
1
Duke University, Department of Internal Medicine, Division of Rheumatology and Immunology, Durham, North Carolina, USA;
[email protected]
.
2
Rheumatology Department, Royal National Hospital for Rheumatic Diseases, Bath, UK.
3
Arthritis Kids South Africa, Johannesburg, South Africa.
4
Department of Internal Medicine, Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
5
Canadian Arthritis Patient Alliance, and Five02 Labs, Inc., Toronto, Ontario, Canada.
6
Spondylitis Association of America, Encino, California, USA; Monique Gore-Massy, BA, Lupus Foundation of America, Washington, DC, USA.
7
Canadian Arthritis Patient Alliance and Patient Advisors Network, Toronto, Ontario, Canada.
PMID:
38224986
DOI:
10.3899/jrheum.2023-0998
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Information Dissemination / methods
Language
Rheumatic Diseases* / complications
SARS-CoV-2